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Background: Debridement is essential for successful wound management. Enzymatic
debridement is commonly utilized in wound care but has been reported to be unsafe
in wounds with significant bacterial bioburden, unless used in conjunction with topical
antimicrobials. We examine this hypothesis with 2 commercially available, commonly
used preparations of enzymatic debriding agents. Materials and Methods: Using a
standard rodent model of a chronically infected granulating wound with bacterial levels
greater than 1 × 105 Colony Forming Units per gram of tissue, commercially available
preparations of collagenase and papain-urea were utilized to investigate the response
of infected wounds to these preparations, and to evaluate their ability to overcome the
inhibition of infection on wound healing. Quantitative bacteriology of tissue biopsies
and wound healing trajectories were used to compare the preparations to saline-treated
negative controls. Results: Collagenase- and papain-urea-treated wounds demonstrated
a reduction in bacterial burden of wounds to < 105 colony forming units/gram of tissue
(P < .05). This decrease in bacterial bioburden occurred rapidly, allowing wounds to
achieve bacterial balance in a short period of time. Wounds treated with enzymatic de-
bridingagentshealedsignificantlyfasterandtogreaterextentthansaline-treatedcontrols
(P < .01); a direct reflection of the decreasing bacterial load of the wound. Conclusions:
Collagenaseandpapain-ureaappearbeneficialandsafeeveninwoundswithhighbacte-
rialloads,andappeartosignificantlyaidextentandrateofhealing,probablybylowering
bacterial burden through their positive enzymatic actions on bacteria and necrotic tissue.
Debridement is one of the essential tools of wound management.1 It is defined as the
removal of nonviable material, foreign bodies, and poorly healing tissue from a wound, and
it facilitates the processes of granulation, contraction, epithelialization, and healing. The
mostdirectformofdebridementissurgicalexcision,althoughotherreasonableoptionsexist
for patients who are poor surgical candidates or who have wounds in need of less aggres-
sive debridement. These alternative debridement options include the following: mechanical
debridement, which is exemplified by wet to dry dressings or pressure irrigation; autolytic
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debridement,inwhichocclusivedressingsallowwoundproteasestoliquefynecrotictissue;
biologic debridement, which utilizes maggot therapy; and enzymatic debridement, which
utilizes agents such as collagenase or papain-urea. Collagenase has been shown to be use-
ful for degredation of collagen and elastin but not fibrin. Papain-urea’s main action is to
solubilize fibrin.
Numerous enzyme preparations have been investigated and used clinically since the
1940s.2 It has been reported that proteolytic enzyme treatment of wounds with substantial
bacteriabioburdenisunsafeunlesstreatedinconjunctionwithtopicalantimicrobials.These
enzymaticagentsdemonstratedrapideschardegradationbutallowedforsignificantbacterial
proliferation and invasion.2−5 These reports were based on studies indicating that enzyme-
treated wounds were associated with increased bacterial counts as well as studies indicating
that topical enzyme treatment of burn wounds was associated with the development of
burn wound sepsis. The potential for systemic sepsis could be reduced by concomitant
use of topical antimicrobial agents along with the topical enzyme treatment regimen.2,3
Collagenase and papain-urea are frequently utilized, when indicated, for chronic wound
care, yet the effects of enzymatic debriding agents on the microbiology of chronic-infected
wounds has not been extensively characterized. Wound preparation methods are necessary
to manage wound healing in an effort to accelerate healing and allow for complete closure
secondarily,ortoprepareforsurgicalclosure.6 Frequentsharpdebridementhasbeenshown
to accelerate wound healing and it has been postulated that enzymatic wound debridement
may therapeutically benefit wound healing in a similar way.1,6 This study evaluates the
microbiologicaleffectsoftheactionsofcollagenaseorpapain-ureainachronicallyinfected
wound model.
METHODS
A standard rodent model of a chronically infected granulating wound was utilized.7−10
All animal experiments were approved by the Bay Pines VAMC Animal Care and Use
Committee.FifteenanesthetizedmaleSprague-Dawleyratsweighing300–350gunderwent
a 30-cm2 full-thickness dorsal scald burn produced by immersion in boiling water for 15
seconds. The wounds were allowed to cool and then were inoculated with 5 × 109 E
coli (ATTC #25922; American Type Tissue Culture, Rockville, Maryland), to produce an
infected wound. E coli was utilized because of its relatively high frequency of isolation
in wounds, its ability to sustain elevated levels of greater than 1 × 105 Colony Forming
Units per gram of tissue, and its previously noted utility in this model to emulate a human
chronically infected burn wound.7 On postwounding day 5, the wound eschar was excised,
resultinginachronicallyinfectedgranulatingwoundwithgreaterthan108 bacteriapergram
of tissue. The animals were divided into 3 groups of 5. Group I wounds were treated daily
with isotonic sodium chloride solution (control). Group II wounds were treated daily with
an application of commercially available collagenase preparation. Group III wounds were
treated daily with a commercially available preparation of papain-urea. Data were collected
twiceperweek.Woundsareaswereevaluatedbyseriallytracingwoundcircumferencesand
performing digital planimetry (Sigma Scan Jandel Scientific, Corte Madera, California).
For each animal’s wound area data, a Gompertz equation was fitted. Comparison among
groups was performed using SAS (SAS/STAT Guide for Personal Computer, Version 6
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Manual,LosAngeles,BMDPStatisticalSoftware,Inc,1988).11,12Quantitativebacteriology
was performed serially by tissue biopsy samples, in previously described standardized
fashion.13
RESULTS
Quantitative bacteriology demonstrated a reduction of tissue bacterial levels, which was
significantly greater in enzyme-treated wounds. Wound bacterial counts decreased rapidly
win the groups treated with enzyme debriding agents. Papain-urea reduced tissue bacterial
levels to <105 per gram of tissue (P < .05), and to a greater extent than isotonic sodium
chloride solution controls or collagenase (Fig 1).
Figure 1. Quantative bacteriology of infected chronic granulating wounds treated with isotonic
sodium chloride solution (control), collagenase, and papain-urea. Decreasing bacterial counts
(Colony Forming Units per gram of tissue) overtime indicate significantly diminished bacterial
burden in wounds treated with papain-urea.
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Figure 2. Woundclosureratesforchronicgranulatingwoundstreatedwithisotonicsodiumchloride
solution (control), collagenase, and papain-urea. Statistically significant accelerated closure rates
and extents for wounds treated with collagenase or papain-urea versus saline control.
Wound closure rates were significantly accelerated in groups treated with collagenase
orpapain-ureaascomparedtosaline-treatedcontrols(P<.05)(Fig2).Closurerateparallels
the rapid decrease in bacterial load and may be a direct result of this effect.
DISCUSSION
Debridement is an integral component for care of wounds of all etiologies that contain
necrotic tissue, high bacterial burden, or other complicating unwanted elements.1 Surgi-
cal (sharp) debridement is the most rapid, direct, and effective methods of debridement.
However, not all wounds or patients are candidates for surgery. Nonsurgical enzymatic de-
bridment presents an alternative to sharp surgical debridement, can be accomplished with
bedside dressing change regimens, and is available to nonsurgeon practitioners.2−6
Enzymaticdebridingagentshavelongbeenusedinburnwoundtreatmentregimensdue
to their effectiveness and ease of use.3−5 However, data would indicate cautious approach
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when utilizing enzymatic agents in burn wounds with significant bacterial bioburdens.2−5
There are concerns that enzymatic debridement in the face of tissue bacterial loads greater
than105 maypredisposetoworseninginvasiveinfection,leadingtosepsis.2−4 Concomitant
topical antimicrobials were recommended in an attempt to avoid this complication.3 This
current experiment evaluates 2 of the most commonly used enzymatic debriding agents,
collagenase and papain-urea, and give evidence that these agents appear to be beneficial
and safe for use in a chronically infected wound model, even in the face of significant
bioburden.
Wound care regimens that are simple and effective have greater compliance and suc-
cess. Simplification of wound care by (safely) reducing the number of preparations used
for care may help improve wound-healing outcomes.
Commercially available collagenase and papain-urea enzymatic debriding agents are
commonly used for wound care and show effectiveness in wound bed preparation. As
compared with previous proteolytic enzyme preparations, both collagenase and papain-
urea appear to reduce bacterial load to a level of 105 or fewer bacteria per gram of tissue;
a level of bacterial burden consistent with normal wound healing (Fig 1). Wounds treated
with collagenase or papain-urea close at an accelerated rate when compared with wounds
treated with isotonic sodium chloride solution (Fig 2). Although this effect is due in part to
reduction of bacterial burden, some of this accelerated wound healing may be due to other
wound healing properties of these specific enzymatic preparations. It appears that because
of their antimicrobial properties and wound healing effectiveness, collagenase and papain-
urea may be safely utilized without concomitant topical antimicrobials in chronic-infected
wounds.
CONCLUSION
Concerns of invasive infection after treatment of burn wounds by enzymatic debridement
have existed for quite some time. Previous experimental and clinical data had substantiated
theseconcernsandresultedinrecommendationstouseconcomitanttopicalantimicrobialsto
avoid this complication. In this current experiment, 2 commonly used enzymatic debriding
agents, collagenase and papain-urea, appear safe and beneficial in wounds with high tissue
levels of bacteria. These agents demonstrate an ability to reduce wound bioburden as well
as promote wound healing. Wounds treated with these enzymatic debriding agents appear
safe to use without concomitant topical antimicrobial therapy.
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